Exact Mass: 629.1247674

Exact Mass Matches: 629.1247674

Found 12 metabolites which its exact mass value is equals to given mass value 629.1247674, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(-)-1-[5-Chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4(R)-hydroxy-L-proline N,N-dimethylamide

1-[5-chloro-1-(2,4-dimethoxybenzenesulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide

C30H32ClN3O8S (629.1598542)


   

Oganomycin A

Oganomycin A

C24H27N3O13S2 (629.0985252)


   

(-)-1-[5-Chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4(R)-hydroxy-L-proline N,N-dimethylamide

(-)-1-[5-Chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4(R)-hydroxy-L-proline N,N-dimethylamide

C30H32ClN3O8S (629.1598542)


   

nelivaptan

nelivaptan

C30H32ClN3O8S (629.1598542)


CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9489; ORIGINAL_PRECURSOR_SCAN_NO 9486 C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9515; ORIGINAL_PRECURSOR_SCAN_NO 9511 CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9534; ORIGINAL_PRECURSOR_SCAN_NO 9531 CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9547; ORIGINAL_PRECURSOR_SCAN_NO 9544 CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9520; ORIGINAL_PRECURSOR_SCAN_NO 9516 CONFIDENCE standard compound; INTERNAL_ID 391; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9563; ORIGINAL_PRECURSOR_SCAN_NO 9558

   

Heptadecafluorooctanesulfonic acid tetraethylammonium salt

Heptadecafluorooctanesulfonic acid tetraethylammonium salt

C16H20F17NO3S (629.0892374)


   

[(2R,3R,4S,5S,6R)-3-acetamido-5-amino-4-hydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

[(2R,3R,4S,5S,6R)-3-acetamido-5-amino-4-hydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate

C18H29N7O14P2 (629.1247674)


   

6-amino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-5-hydroxy-5-methyl-3,4-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

6-amino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-5-hydroxy-5-methyl-3,4-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

C19H29N5O15P2 (629.1135344)


An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

   

1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione

1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione

C19H29N5O15P2 (629.1135344)


An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

   

5-amino-1,8-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4a-methyl-1,4a,4b,8,8a,8b-hexahydrocyclobuta[1,2-d:4,3-d]dipyrimidine-2,4,7(3H)-trione

5-amino-1,8-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4a-methyl-1,4a,4b,8,8a,8b-hexahydrocyclobuta[1,2-d:4,3-d]dipyrimidine-2,4,7(3H)-trione

C19H29N5O15P2 (629.1135344)


   

(S)-2-(4-(2-bromoacetamido)benzyl)-DOTA

(S)-2-(4-(2-bromoacetamido)benzyl)-DOTA

C25H36BrN5O9 (629.1696266)


   

2-[6-[Bis(carboxymethyl)amino]-5-[2-[2-[bis(carboxymethyl)amino]phenoxy]ethoxy]-1-benzofuran-2-yl]-4,5-dihydro-1,3-oxazole-5-carboxylic acid

2-[6-[Bis(carboxymethyl)amino]-5-[2-[2-[bis(carboxymethyl)amino]phenoxy]ethoxy]-1-benzofuran-2-yl]-4,5-dihydro-1,3-oxazole-5-carboxylic acid

C28H27N3O14 (629.1492962)


   

dCMP-dTMP

dCMP-dTMP

C19H29N5O15P2 (629.1135344)


A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of 2-deoxycytidine 5-monophosphate and thymidine 5-monophosphate.